Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119837) titled 'A Study on the Application of Oliceridine Combined with Ciprofol for Intravenous Anesthesia in Painless Induced Abortion Procedures' on March 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shaanxi Nuclear Industry No. 215 Hospital
Condition:
Induced Abortion
Intervention:
Sufentanil Group:Sufentanil (0.1 µg/kg) combined with ciprofol (0.4 mg/kg).
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: Sufentanil Group:57;Oliceridine Group:57;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org...